samir kapadia
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, samir kapadia sits in the upper half of US sponsors by registered trial count (#4,887 of 15,751 sponsors by registered trial count).
samir kapadia: 2 sponsored US clinical trials, none currently recruiting.
samir kapadia sponsors 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. The most-studied condition in this pipeline is Mitral Regurgitation, with 1 trials.
Mid-pack sponsor footprint
samir kapadia is in the upper half of sponsors by trial count (#4,887 of 15,751 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.
Indexed trials (enrollment closed)
2 total, page 1 of 1
Therapeutic Areas
How the samir kapadia archive is shaped
2 indexed studies, none listed as recruiting (0% open); 1 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Mitral Regurgitation (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.